Search

Search Constraints

You searched for: Author/Creator Mustea, Alexander

Search Results

11. Evolving treatment landscape of advanced endometrial cancer – A current perspective from a German tertiary referral center for gynecological oncology. (March 2023)

12. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy–Innovative Models Prolong Survival (OCTIPS) Consortium. (July 2017)

13. Fluorescence in situ hybridization test for detection of endometrial carcinoma cells by non‐invasive vaginal swab. Issue 3 (10th January 2023)

14. Heat Shock Protein HSP27 Secretion by Ovarian Cancer Cells Is Linked to Intracellular Expression Levels, Occurs Independently of the Endoplasmic Reticulum Pathway and HSP27's Phosphorylation Status, and Is Mediated by Exosome Liberation. (23rd February 2017)

16. Patient participation in multidisciplinary tumor conferences: How is it implemented? What is the patients' role? What are patients' experiences?. (17th August 2021)

18. Role of tumour-free margin distance for loco-regional control in vulvar cancer—a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study. (December 2016)

19. Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer. (December 2020)

20. Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB–IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study. Issue 12 (8th December 2020)